Home Updates ACT-AD Urges House and Senate Appropriations Subcommittee Leadership to Increase Funds for FDA Drug Review Activities
Update

ACT-AD Urges House and Senate Appropriations Subcommittee Leadership to Increase Funds for FDA Drug Review Activities

  March 31, 2008 at 5:38 pm

ACT-AD urged House and Senate Appropriations Subcommittee leadership to increase funds for FDA drug review activities in FY 2009.
Read Letter

File Attachments
  actadletter (1M PDF)
Categories:
Uncategorized
  Recent Updates
Featured Image
ACT-AD at the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
October 31, 2018
ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance
June 15, 2018
Researchers Reverse Alzheimer’s Disease in Mouse Models
February 10, 2018
Experimental Drug Could Be Viable Treatment for Alzheimer’s Disease
January 19, 2018
  Newsletter Signup